Verastem Oncology to Present at the H.C. Wainwright BioConnect 2021 Conference
January 05 2021 - 7:00AM
Business Wire
Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology),
a biopharmaceutical company committed to advancing new medicines
for patients battling cancer, today announced that the Company will
present at the virtual H.C. Wainwright BioConnect 2021 Conference.
The fireside chat will be made available for on-demand listening
beginning Monday, January 11, 2021 at 6:00 a.m. EST.
The webcast of the fireside chat will be available on the
“Media” section of the Company’s website at www.verastem.com under
“Events & Presentations”.
About Verastem Oncology
Verastem Oncology (Nasdaq:VSTM) is a development-stage
biopharmaceutical company committed to the development and
commercialization of new medicines to improve the lives of patients
diagnosed with cancer. Our pipeline is focused on novel small
molecule drugs that inhibit critical signaling pathways in cancer
that promote cancer cell survival and tumor growth, including
RAF/MEK inhibition and focal adhesion kinase (FAK) inhibition. For
more information, please visit www.verastem.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210105005286/en/
Investors: Ajay Munshi VP, Corporate Development +1 781-469-1579
amunshi@verastem.com
Media: Lisa Buffington VP, Corporate Communications +1
781-292-4205 lbuffington@verastem.com
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From Sep 2023 to Sep 2024